Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

312.89 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4
Open 312.89
Bid (Size) 302.00 (1)
Ask (Size) 318.25 (2)
Prev. Close 312.89
Today's Range 312.89 - 312.89
52wk Range 253.95 - 370.82
Shares Outstanding 340,107,539
Dividend Yield 1.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
NYSE:CI is an undervalued gem with solid fundamentals.
THE CIGNA GROUP (NYSE:CI): good value for what you're paying. 
Via Chartmill

Performance

YTD
+0.90%
+0.90%
1 Month
-9.68%
-9.68%
3 Month
-10.26%
-10.26%
6 Month
-12.40%
-12.40%
1 Year
+1.19%
+1.19%

More News

Read More
Investors seeking growth at a reasonable cost should explore NYSE:CI.
Via Chartmill
Jim Cramer: Buy Broadcom, But Stay Away From These Stocks
Via Benzinga
11 Analysts Assess Cigna: What You Need To Know
Via Benzinga
Here's How Much You Would Have Made Owning Cigna Stock In The Last 15 Years
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,200 Today
Via Benzinga
A Glimpse Into The Expert Outlook On Cigna Through 11 Analysts
Via Benzinga
NYSE:CI: good value for what you're paying.
Via Chartmill
Why Cigna Group Stock Got Mashed on Monday
Via The Motley Fool
Stocks Fall As Treasury Yields, Dollar Rise; Nvidia Hits Record Highs: What's Driving Markets Monday?
Via Benzinga
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Via Investor's Business Daily
NYSE:CI is showing good growth, while it is not too expensive.
Via Chartmill
Market Briefing For Monday, Oct 21
Via Talk Markets
SAP, Nucor And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO
Via Benzinga
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
Via Benzinga
3 Dividend Growth Stocks Set to Supercharge Your Portfolio
Via MarketBeat
Topics ETFs
Shamus McGuire Champions Advanced Technology Integration in New Jersey’s Healthcare Sector
Via Get News
Topics Artificial Intelligence
Exposures Artificial Intelligence
Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Healthcare Executive Shamus McGuire Highlights Work-Life Balance in New Jersey
Via Zexprwire
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
Via Benzinga
CVS Health in Focus as Activist Investor Prepares for High-Level Talks
Via Benzinga
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.